Pure Global

Reducing Opioid Prescription After Kidney Stone Removal Surgery - Trial NCT05353478

Access comprehensive clinical trial information for NCT05353478 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Recruiting. The study focuses on Kidney Stone. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05353478
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT05353478
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Reducing Opioid Prescription After Kidney Stone Removal Surgery
Reducing Opioids After Percutaneous Stone Surgery

Study Focus

Kidney Stone

Observational

Sponsor & Location

Mayo Clinic

Rochester, United States of America

Timeline & Enrollment

N/A

Jun 06, 2022

Jun 01, 2023

100 participants

Primary Outcome

Unused opioid prescriptions

Summary

The purpose of this study is to implement and assess a standard way of prescribing opioid
 pain medication following PCNL (a kidney stone removal surgery) to ensure patients are being
 discharged with an appropriate quantity of pain management medication.

ICD-10 Classifications

Kidney dialysis
Small kidney, unspecified
Disorder of kidney and ureter, unspecified
Injury of kidney
Unspecified kidney failure

Data Source

ClinicalTrials.gov

NCT05353478

Non-Device Trial